Director Jeryl Hilleman resigns from Minerva Neurosciences Board; Audit Committee roles reassigned

Minerva Neurosciences, Inc.

Jeryl Hilleman resigns from Board and Audit Committee Chair, effective August 6, 2024.
Jan van Heek appointed as new Audit Committee Chair; Dr. David Kupfer added to committee.
Resignation not due to any disagreement with the Company, management, or Board.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jeryl Hilleman

Director and Chair of the Audit Committee

NERV · Minerva Neurosciences, Inc.

Effective: 2024-08-06
Filed: May 30, 2024, 7:59 PM ET

On May 29, 2024, Jeryl Hilleman notified the Board of Directors (the “Board”) of Minerva Neurosciences, Inc. (the “Company”) of her intention to resign as a member of the Board, effective August 6, 2024, including from her role as Chair of the Audit Committee of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeryl Hilleman resigned as Director and Chair of the Audit Committee at Minerva Neurosciences, Inc..

Action: resigned
Role: Director and Chair of the Audit Committee

Exact text from the filing

On May 29, 2024, Jeryl Hilleman notified the Board of Directors (the “Board”) of Minerva Neurosciences, Inc. (the “Company”) of her intention to resign as a member of the Board, effective August 6, 2024, including from her role as Chair of the Audit Committee of the Board.

View on SEC.gov

Minerva Neurosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-150357

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.